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ABSTRACT Calcium (Ca21) is an important second messenger and has been the subject of numerous experimental mea-
surements andmechanistic studies in intracellular signaling. Calcium proﬁle can also serve as a useful cellular phenotype. Kinetic
models of calciumdynamics provide quantitative insights into the calcium signaling networks.We report here the development of a
complex kinetic model for calcium dynamics in RAW 264.7 cells stimulated by the C5a ligand. The model is developed using the
vast number of measurements of in vivo calcium dynamics carried out in the Alliance for Cellular Signaling (AfCS) Laboratories.
Ligand binding, phospholipase C-b (PLC-b) activation, inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) dynamics, and calcium
exchangewithmitochondria and extracellularmatrix haveall been incorporated into themodel. Theexperimental data include data
from both native and knockdown cell lines. Subpopulational variability in measurements is addressed by allowing nonkinetic
parameters to vary across datasets. Themodel predicts temporal response of Ca21 concentration for various doses of C5a under
different initial conditions. The optimized parameters for IP3R dynamics are in agreement with the legacy data. Further, the half-
maximal effect concentration of C5a and the predicted dose response are comparable to those seen in AfCS measurements.
Sensitivity analysis shows that the model is robust to parametric perturbations.
INTRODUCTION
Cytosolic calcium is a secondmessenger and plays an important
role in intracellular signaling (1). Cytosolic Ca21 is involved
in regulating numerous cellular functions by regulating the
activity of proteins such as calmodulin (2), calreticulin (3–5),
and calcineurin (6). Dynamic changes in intracellular calcium
serve both as an important indicator of cellular events and a
quantitative measure of cellular response to stimuli.
Basic mechanism of calcium dynamics
In a eukaryotic cell, the average cytosolic Ca21 concentra-
tion ([Ca21]i) is maintained low (0.05–0.5 mM), whereas
Ca21 concentrations in extracellular space and endoplasmic
(or sarcoplasmic) reticulum (ER/SR) ([Ca21]ER) are several
thousands times higher (7). This large concentration gradient
of Ca21 between different cellular compartments is utilized
by cells to generate rapid intracellular Ca21 changes through
receptor-mediated mechanisms. In nonexcitable cells, such
as macrophages, ligand-induced release of calcium from the
ER is the main initiator of calcium dynamics. In excitable
cells, other sources that initiate dynamics include the calcium
inﬂux through voltage-gated channels on the plasma mem-
brane (PM) (8–11). Both these eventually lead to increased
activation and opening of the inositol 1,4,5-trisphosphate
(IP3) receptor (IP3R) channels on the ER membrane through
either increased hydrolysis of phosphatidylinositol 4,5-
bisphosphate (PIP2) into IP3 (12–14) or local increase in
[Ca21]i leading to calcium-induced calcium release (CICR)
(15–17). Calcium release from the ER leads to increased
Ca21 in the cytosol. Most of the calcium released binds to
various proteins, such as calmodulin (CaM). Calcium is also
pumped back to the ER by the sarco(endo)plasmic reticulum
calcium ATPase (SERCA) pump. Some calcium is also
expelled to the extracellular space through an Na1/Ca21
exchanger (NCX) and the plasma membrane calcium ATPase
(PMCA) pump. Calcium exchange with the mitochondria
also has been observed at elevated levels of [Ca21]i. If Ca
21
concentration in the ER becomes quite low, calcium can
enter the cell as calcium-release-activated current (CRAC)
through store-operated channels (SOC) on the plasma mem-
brane (18–20). Finally, calcium response can propagate to
nearby cells connected through gap-junctions resulting in
calcium waves (20).
Variation across different cell types
Cytosolic Ca21 can be measured relatively easily using ﬂuo-
rescence and dye-based methods (21,22) at high sample rates
(one sample every few seconds) (23). Recent reviews by Van
Den Brink et al. (21) and Takahashi et al. (22) deal with
elaborate descriptions of various methods of measuring free
[Ca21] and calcium ﬂuxes between various compartments,
such as the cytosol, the ER, and the mitochondria. Calcium
levels can vary substantially from one cell type to another.
For example, in excitable cells such as neuronal cells and mus-
cle cells, for which most calcium models and measurement
techniques have been developed (13,21,24–28), basal [Ca21]i
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is in the 0.2–0.5 mM range, whereas in nonexcitable cells
such as macrophages, including RAW 264.7 cells (29,30), it
is between 0.03 and 0.1 mM. In macrophages, due to their
nonexcitable nature, oscillations are generally not observed,
as evidenced by the Alliance for Cellular Signaling (AfCS)
calcium data (29) and discussed in (30–32). In fact, the maxi-
mal changes in [Ca21]i (spatially averaged) are also only
;0.05–0.1 mM, except when cells are treated with strong
activators such as the bacterial toxin lipopolysaccharide (30).
The need for a model for calcium dynamics in
RAW 264.7 cells
Recently, AfCS has conducted a large array of experiments
to measure the temporal response of cytosolic calcium in
RAW 264.7 cells in response to various ligands. RAW 264.7
cells are a macrophage-like, Abelson leukemia virus trans-
formed cell line derived from BALB/c mice (AfCS protocol
PP00000226 (23,33)). Considering the importance of calcium
signaling, substantial efforts have been devoted to develop
mathematical models for calcium dynamics. However, much
of the work has focused on excitable cells, such as neuronal
cells (13,27) and muscle cells (10,11,21,24–26,28), in which
calcium oscillations are prevalent. Recent efforts have also
focused on nonexcitable cells (12,13,34). Although literature
is replete with simple, as well as complex, models of calcium
signaling, including those by Fink et al. (35), Mishra and
Bhalla (13), and Lemon et al. (12), there are no models of
calcium dynamics in RAW 264.7 cells in the published
literature. The model presented by Mishra and Bhalla (13),
which incorporates the mechanisms for G-protein signaling,
IP3R channels, IP3 metabolism, and binding of calcium with
many proteins such as calmodulin, is the most comprehen-
sive detailed kinetic model for mammalian cells. Most of the
parameters used for simulation of the model are taken from
the literature and are robust for making qualitative compar-
isons for various cell types. However, these parameter values
may not be able to capture the ﬁne quantitative features of
data for a given cell type. In fact, a comparison of the time
course predicted by Lemon et al. (12) for a nonspeciﬁc cell
type and by Fink et al. (35) for neuronal cells with the time
course in AfCS experiments reveals that the effective time
constant in AfCS data for the rise phase is several times
larger than in Lemon et al. (12) and Fink et al. (35), whereas
the decay phase is more gradual than in Fink et al. (35) and
much faster than in Lemon et al. (12). Although precise quan-
titative comparisons/predictions of features such as peak
height are not mandated from calculations, it is essential to
capture overall temporal variations for a model to be accurate
and predictive for describing calcium dynamics. Thus, there
is a clear need for some cell-speciﬁc constraining of the pa-
rameters. One way to carry out constraining of the param-
eters is to tweak each parameter in a trial-and-error fashion.
The alternative and arguably the best way is to use cell-
speciﬁc in vivo data to develop a systems-level model. The
known biochemistry and other constraints from legacy data
must be included to maintain the qualitative generality of the
results. RAW 264.7 cells are different from other cells such
as muscle cells not only in size but also in the basal level of
[Ca21]i, as stated earlier. Further, AfCS experiments have
shown that calcium response in RAW cells is nonoscillatory
and exhibits just one peak after applying a ligand. Thus, it is
reasonable to expect differences in the values of some of the
lumped/effective kinetic parameters besides differences in
the species concentrations in various cell types. Cell-speciﬁc
modeling of calcium signaling, including the estimation/
measurement of parameters, is quite important for real-life
applications such as drug-dose response, and applications of
systems biology. Also, in systemic models that include many
processes and parameters, many different parameter ranges
can yield different qualitative responses. Hence, even if one
is interested in only qualitative results, some constraining of
the parameters using cell-speciﬁc data is desired.
Recent AfCS experiments have revealed a new and very
challenging problem. Different cell populations (cloned from
the same parent cell), when triggered by a stimulus of the
same strength, result in quantitatively as well as qualitatively
different responses (different peak heights, rise times, etc.).
According to our current understanding, the underlying cause
is the variation in the unmeasurable concentrations of hun-
dreds of species (components) inside the cells. This varia-
bility could be due to intrinsic sources, such as noise in gene
expression (36), as well as extrinsic noise, such as unsyn-
chronized cell cycles in different experiments. Though some
of these ﬂuctuations across cells get averaged out in cell
populations, a nontrivial variation is still observed from one
population to another. This variation is observed even in the
basal levels in unstimulated and stimulated control cell lines
and in knockdown cell lines, in addition to the variability
after stimulation with ligands. If the basal levels were similar
across different subpopulations (datasets), a common set of
parameter values could have been used and then a knock-
down could be modeled by modifying the parameter related
to the knockdown process, e.g., the concentration of the rel-
evant protein. The substantial ‘‘subpopulational variability’’
in the basal level required us to employ a special modeling
approach in which some parameters are allowed to vary
across different datasets. The AfCS data also includes a large
set of perturbation data on the knockdown of proteins af-
fecting the temporal characteristics of calcium dynamics.
This data has been used for both modeling and validation of
our context-speciﬁc models. The ligand used in this study is
the complement 5a (C5a), a potent mediator of inﬂammation
(37–44). An ordinary differential equation-based model is de-
veloped to understand calcium dynamics in RAW264.7 cells.
The ﬁrst part of this two-part article deals with the devel-
opment of a kinetic model using the AfCS data exhibiting
subpopulational variability and prediction of dose response
of C5a. Part 2 deals with the prediction of knockdown
response and long-term response using the model developed
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in this article. Our modeling approach allowed us to utilize in
vivo data exhibiting variability across different subpopula-
tions. The resulting model elucidates the central role of phos-
pholipase C (PLC) b (PLCb) and IP3 for calcium dynamics.
Using the model, the efﬁcacy of C5a is characterized and the
robustness of calcium response is analyzed using global sen-
sitivity analysis.
MATERIALS AND METHODS
Experimental data
We have utilized the time-course data on [Ca21]i response in macrophage
RAW 264.7 cell populations made available by the AfCS (45). Owing to
limitations of space, we refer to the AfCS website for the necessary details
pertaining to experimental data (45). In brief, free [Ca21]i is measured using
the Ca21-sensitive ﬂuorescent dye fura-2 (AfCS protocol PP00000211
(23)). As described on the AfCS Web site (23) and in the literature (46,47),
free [Ca21]i is computed from the ratio of the intensities of ﬂuorescent light
at two wavelengths (340 nm and 380 nm). The intensities are actually related
to the amount of calcium-bound fura-2. However, using the rapid buffering
approximation for fura-2, as well as other buffers present in the cytosol, it is
possible to back out free [Ca21]i from the intensity measurements. In the
Results section, we show that the rapid buffering approximation is valid, i.e.,
for a small perturbation in [Ca21]i, the new equilibrated free [Ca
21]i is
reached much earlier than the next measurement. We use data from native
cells as well as from knockdown cell lines. The knockdowns were carried
out using short hairpin RNA interference (shRNAi). Data from four time-
courses are used for constraining/estimating the parameters. Additional
description of the data used is given in Supplementary Material (Prepro-
cessing of time-course data).
Mathematical model of calcium dynamics in
RAW 264.7 cells
A simpliﬁed model for calcium signaling that incorporates most of the
mechanisms included in the existing models has been developed (Fig. 1).
This simple model, however, includes several mechanisms explicitly so that
knockdown of important proteins, such as G-protein-coupled receptor (GPCR)
kinase (GRK), Arrestin, Gbg, and Ga,i, can be modeled quantitatively. We
note that although these mechanisms have been modeled by several re-
searchers to study G-protein signaling (48–51), they have not been included
in most models for calcium signaling. Although the model by Lemon et al.
(12) does include these details, the authors assumed a constant ligand con-
centration, which is appropriate only for saturating concentrations.
Mechanisms
Fig. 1 A shows an overall schematic of ligand-induced release of calcium
from endoplasmic reticulum (ER) into cytosol, binding of calcium (Cai) to
proteins (Pr) in the cytosol (shown) and in the ER (not shown), and other
calcium-exchange ﬂuxes to/from the ER, the extracellular space, and
mitochondria. In the basal state, the channel ﬂux from the ER, Jchis very
small and the leakage ﬂux from the ER, JER;leak; is nearly balanced by the
Ca21 uptake back into the ER by SERCA pump, JSERCA: Similarly, in the
basal state, net ﬂux across the mitochondria and the PM is also individually
zero. Thus, the inﬂux to mitochondria, Jmit;in; is balanced by the efﬂux from
the mitochondria, Jmit;out: The Ca
21 outﬂux from cytosol to the extracellular
matrix (ECM) is mediated by the PMCA (JPMCA) and the Na
1/Ca21
exchanger (JNCX). The inﬂux across the plasma membrane consists of a
nonspeciﬁc leakage ﬂux, JPM;leak; and a speciﬁc ﬂux that combines many
ﬂuxes, including the entry through store-operated channels in response to
ER depletion and other effects. Following the approach of Hofer et al. (20),
in this work, this speciﬁc ﬂux, JPM;IP3dep; has been assumed to be dependent
on [IP3]. Ca
21 binds to buffer proteins in all the three compartments, the
cytosol, the ER, and the mitochondria. The assumption of rapid buffering
kinetics suggested byWagner and Keizer (52) and later used by Lemon et al.
(12) has been utilized in this model as well. More details, including the
expressions for the ﬂuxes, are presented in the next section (mathematical
representation). Fig. 1 B shows the modules and reactions (both simple and
lumped) that have been modeled explicitly. It can be noted that since the
only measurement available to control the size of the model is [Ca21] not all
isoforms of different proteins are included in the model. For example, only a
generic form of the protein PLCb is included. Further, the use of lumped
reactions helps reduce the number of state variables by avoiding explicit
modeling of some intermediate complexes.
A text-based prototype reaction interpreter has been developed that can
read both simple and complex reactions. The simple reactions have law of
mass action rate expression, whereas lumped reactions follow Michaelis-
Menten (M-M) kinetics or Hill dynamics. More complex formats include
modulation (law of mass action, M-M, or Hill dependence). Some examples
of the reactions are presented in Table S1 (Supplementary Material).
Lumped-reaction formats are quite useful for model simpliﬁcation.
Various modules involved in ligand-induced release of calcium from ER
are discussed below. In short, binding of the ligand (C5a, denoted by L) to its
receptor (C5aR, denoted by R) leads to the activation of the receptor, which
in turn leads to the activation of G-protein Gi. Free Gbg binds with PLCb and
activates it, resulting in increased hydrolysis of PIP2 into IP3. Increase in the
IP3 level results in increased release of calcium from the ER.
Receptor module. Reactions 1–11 (Fig. 1 B, box 1) are as follows.
Reaction 1 is activation of the receptor due to ligand binding. Reaction 2
represents binding of GRK to Gbg and is very fast. Reactions 3 (catalyzed by
GRK) and 4 (catalyzed by GRK.Gbg) represent desensitization of the ligand-
bound active receptor (L.R), due to its phosphorylation. The activity of GRK
is enhanced by the PKC.DAG.Cai complex due to increased phosphoryl-
ation, resulting in a negative feedback on [L.R] (53,54). This effect on the
rate of reaction 3 is modeled as an enzymatic activation by calcium to avoid
explicit modeling of the complexes. Reaction 5 is the dissociation of ligand
and phosphorylated receptor (12,49,50). Reactions 6 and 7 are for inter-
nalization of the ligand-bound phosphorylated receptor, L.Rp (55). Reaction
7 is catalyzed by Arrestin. Reactions 8–10 together constitute receptor re-
covery. Reaction 8 is the dissociation of the internalized ligand-bound
phosphorylated receptor, L.Ri, into the free ligand and the phosphorylated
receptor (internalized form), Rp,i (56). The internalized free ligand gets
ubiquitinated and degraded. Rp,i then gets dephosphorylated and recycled
back to the surface through reaction 9 (12,48). A small part of Rp,i also can
get degraded (reaction 10). Reaction 11 is fresh receptor generation (48,51).
To the best of our knowledge, in most existing models, GRK and arrestin
(Arr) have not been explicitly included in calcium signaling studies, prob-
ably because knockdown data on these proteins have not been quantitatively
analyzed with respect to kinetic modeling. The rate constant for reaction 4 is
much higher (;100-fold) than for reaction 3, so that most phosphorylation
occurs due to GRK.Gbg when ligand is present and due to GRK during the
basal state. Similarly, internalization (reactions 6 and 7) is enhanced sub-
stantially by arrestin (buffered). Reactions 3, 4, and 7 are lumped-enzymatic
reactions, as described below:
Reaction 3: ½GRK; CaiL:R/
L:Rp ðGRK andCai are enzymesÞ
Reaction 4: ½GRK:GbgL:R/L:Rp ðGRK:Gbg is an enzymeÞ
Reaction 7: ½ArrL:Rp/L:Ri ðArr is an enzymeÞ
GTPase cycle module. Reactions 12–16 (Fig. 1 B, box 2) depict GTPase
cycle. Reactions 12 and 13 take place in the absence of active receptor and
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GTPase activating protein (GAP), respectively. Reaction 15 is similar to
reaction 12 but is catalyzed by L.R, and reaction 16 is similar to reaction 13
but is catalyzed by GAP (A, RGS) (57). A more detailed description of the
GTPase cycle, similar to the three-cube model in Fig. 1 A of Bornheimer
et al. (58) but with simpliﬁcation of reactions GD4G4GT into GD4GT
(Fig. 1 B, reaction 12) and explicit modeling of Gbg and Ga,i, was included
in a detailed model, but its ﬁt to one set of basic experimental data
(stimulation with 250 nMC5a) was similar to the compact model of Fig. 1 B.
Hence, to reduce computational complexity, only the simpler model (Fig.
1 B) is used for further analysis with knockdown data. Additional discussion
on this simpliﬁcation is presented in Supplementary Material (Approxima-
tions and the lumped/simpliﬁed mechanisms in the model). Reactions 15 and
16 are lumped-enzymatic reactions, where T is GTP, D is GDP, and A is the
GAP RGS.
Reaction 15: ½L:RGiD1T/Ga;iT1Gbg1D
ðL:R is an enzymeÞ
Reaction 16: ½AGa;iT/Ga;iD1 Pi ðA is an enzymeÞ
IP3 module. In the basal state, most of the IP3 is generated due to slow
hydrolysis of PIP2 (reaction 17), since free Gbg is present in very small
amounts. Upon G-protein activation, dissociated Gbg binds to PLCb. Cytosolic
Ca21 (Fig. 1 B, box 3, Cai) can bind to both PLCb and PLCb.Gbg. Bind-
ing afﬁnities for Gbg and calcium-bound forms of PLCb are ;10 times
higher than that of free PLCb (13). Each of PLCb.Gbg, PLCb.Cai and
PLCb.Gbg.Cai catalyze hydrolysis of PIP2, but PLCb.Gbg.Cai is the most
potent. In our model, for simpliﬁcation, a lumped-enzymatic reaction is
used to model the enhancement due to PLCb.Gbg.Cai (see reaction 18 (Fig.
1 B, box 3)):
Reaction 18: ½Cai; Gbg; PLCb PIP2/IP31DAG
ðenzyme is a ternary complex of Cai; Gbg; and PLCbÞ:
As explained in Supplementary Material (Approximations and the
lumped/simpliﬁed mechanisms in the model), the rate expression of the
above reaction is a close approximation to an expression derived based on
the assumption that all the four reversible reactions related to PLCb are in
equilibrium. Further, it is assumed that the enzymatic effect of PLCb.Gbg
and PLCb.Cai is captured through suitable increase in the value of the rate
constant. The amount of Gbg bound to PLCb complexes (estimated to be
;10% of free Gbg) is ignored for Gbg balance (Supplementary Material,
Details of explicitly modeled reactions) in the reduced model; if all other
species are included, then little reduction is achieved, and therefore it would
be appropriate to model all reactions explicitly. Since PLCb is not used in
any other reaction in our model, PLCb denotes the total PLCb (buffered).
Reactions 19 and 20 (Fig. 1 A) are simpliﬁed and highly lumped repre-
sentations of IP3 metabolism, i.e., degradation/conversion to/from other ino-
sitol phosphates and back to PIP2, with only one intermediate pseudospecies,
namely, IP3,p or IP3 product (12). Since oscillation is not observed in the
experimental data on C5a stimulation of RAW cells, this simple represen-
tation is considered sufﬁcient. As Mishra and Bhalla (13) have noted, such a
simple description may be insufﬁcient to model oscillatory response, even
though Marhl et al. (59) have shown that interactions with the mitochondria
(included in our model) can result in oscillations, especially above cytosolic
[Ca21] of ;0.5 mM.
It should be noted here that the free Gbg subunit is responsible for the
activation of PLCb, as opposed to activation by the free a subunit of a
G-protein, e.g., GaqT (G-protein Gq) upon activation of P2Y2 receptors, as
presented by Lemon et al. (12). For the G-protein Gi, the a subunit, i.e.,
GaiT, does not bind to PLCb. Gbg also has been implicated in calcium
oscillations during fertilization (60).
FIGURE 1 A simpliﬁed model for
calcium signaling including calcium in-
ﬂux, ER, and mitochondrial exchange
and storage, used in the conceptual-
model-based computation. (A) Overall
schematic model. The ligand C5a binds
to its receptor C5aR on the plasma mem-
brane, activating G-protein Gi. The
free subunit Gbg binds to and activates
PLCb, which hydrolyzes PIP2 into IP3
and DAG. IP3 binds to its receptor on the
ER membrane and the IP3R channels
open to release calcium into the cytosol.
Other calcium ﬂuxes (e.g., with mito-
chondria and extracellular space) are
also shown. (B) The mechanisms for the
receptor module (box 1), the GTPase
cycle module (box 2), and IP3-generation
module (box 3), and the feedback effects
(boxes 1 and 4). PIP2, phosphatidylino-
sitol 4,5-bisphosphate; IP3, inositol 1,4,5-
trisphosphate; IP3R, IP3 receptor; IP3,p, a
lumped product of IP3 phosphorylation;
Cai, cytosolic Ca
21; ER, endoplasmic
reticulum; CICR, calcium-induced cal-
cium release; SERCA, sarco(endo)
plasmic reticulum calcium ATPase;
PMCA, plasma membrane calcium
ATPase; NCX, Na1/Ca21 exchanger;
mit (subscript), mitochondria; L, ligand C5a; R, receptor C5aR; GRK, G-protein-coupled receptor kinase; CaM, calmodulin; PLCb, phospholipase C-b; GAP,
GTPase activating protein; RGS, regulator of G-protein signaling; DAG, diacylglycerol; PKC, protein kinase C; Pi, phosphate.
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Feedback effects from calmodulin. Calmodulin binds with intracellular
Ca21 (Cai) (Fig. 1 B, box 4, reaction 21), and the resulting complex binds
with GRK (reaction 22), reducing the effective amount of free GRK that can
bind Gbg. The result is reduced phosphorylation of the active receptor, and
thus, this constitutes a functional positive feedback.
Mathematical representation of the model
The state variables are described by a set of ordinary differential equations
(61) involving the Ca21 ﬂuxes between different cellular compartments and
other ﬂuxes due to reactions. The state variables used to model the details of
ligand-induced generation of IP3 are [L], [R], [L.R], [Gbg], [GRK], [L.Rp],
[Rp], [L.Ri], [Rp,i], [Rpool], [Ga,iT], [Ga,iD], [PIP2], [IP3], and [CaM] (15 of
them). Calcium dynamics introduces four more state variables, [Ca21]i,
[Ca21]ER, h, and [Ca
21]mit. [Ca
21]ER and [Ca
21]mit denote the concentration
of free Ca21 in the ER and mitochondria, respectively; h is explained later.
Thus, the model has 19 state variables. The quantities of all chemical species
are in terms of their concentrations, normalized with respect to a unit volume
of the cytosol. Since, during optimization, most unknowns, e.g., parameters
and initial conditions, are speciﬁed in terms of a range rather than unique
values, whenever needed, a cytosolic volume of 10 pL (picoliter) or cell di-
ameter 27 mm, typical for large macrophages, has been used.
The reaction ﬂuxes, the related parameters, and the differential equations
for the 15 state variables related to the reactions are given in Supplementary
Material, Details of explicitly modeled reactions. Moieties (conservation
relations) have been used to reduce the number of state variables by com-
puting the concentrations of some species. The expressions for the other
four state variables and ﬂuxes, related to the dynamics of calcium, are
given below.
Equations for calcium dynamics
bi; bER; andbm are the ratio of free calcium to total (free and bound)
calcium in the cytosol, ER, and mitochondria, respectively, assuming fast
buffering (equilibrium) with calcium-binding proteins. A ﬁxed value of bmis
used. rER is the ratio of the ER volume to the volume of the cytosol and rm is
the ratio of the volume of the mitochondria to that of the cytosol. The
expressions for bi and bER are
bi ¼ 11
Prtot;e3Km;e
ðKm;e1 ½Ca21 iÞ2
1
Prtot;x3Km;x
ðKm;x1 ½Ca21 iÞ2
 !1
;
and bER ¼ 11
Prtot;ER3Km;ER
ðKm;ER1 ½Ca21 ERÞ2
 !1
; (2)
where Prtot,e is the total concentration of endogenous buffer (Ca
21-binding
proteins) in cytosol, Km,e is the dissociation constant for binding of Ca
21
to endogenous buffer in the cytosol, Prtot,x and Km,x are the corresponding
quantities for binding of Ca21 to the exogenous/mobile buffer (fura-2) in
cytosol, Prtot,ER is the total buffer in the ER, and Km,ER is the dissociation
constant for binding of Ca21 to the buffer in the ER.
THE FLUX OF CALCIUM FROM ER TO CYTOSOL THROUGH THE IP3R CHANNEL. De Young
and Keizer (62) have developed a detailed model for activation/deactivation
of IP3R channels that captures the CICR effect and the biphasic behavior
of the channel opening at low and extremely high calcium concentrations.
Li and Rinzel (63) simpliﬁed the De Young and Keizer model (62) using
time-scale analysis, which was also used by Fink et al. (35) to simulate
spatial variations in neuroblastoma cells. The channel ﬂux is given by
Jch ¼ vmax;ch3Popen3 ð½Ca21 ER  ½Ca21 iÞ
Popen ¼ ½IP3½IP31KIP3
  ½Ca21 i
½Ca21 i1Kact
 
h
 3
; (3)
where Popen is the IP3R channel instantaneous open fraction or probability
and h is the fraction of IP3R to which calcium is not bound to the inhibitory
site. KIP3 is the dissociation constant for binding of IP3 on the IP3R channel.
Kact is the dissociation constant of Ca
21 binding to the activation site of the
IP3R channel. In the above expression, the second term arises due to the
binding of calcium to the activation site on the IP3R. Thus, at low calcium
concentration, calcium has an activation effect on Jch. However, at higher
levels of calcium, the equilibrium value of h decreases with increasing
[Ca21]i (see the differential equation for h). This is due to binding of calcium
to the low-afﬁnity inhibitory site on the IP3R channel and results in biphasic
response of Jch with respect to [Ca
21]i.
FLUX THROUGH THE SERCA PUMP BACK TO ER
JSERCA ¼ Vmax½Ca21 2i =ð½Ca21 2i 1K2PÞ; (4)
where Vmaxis the maximal rate of SERCA pump uptake and KP is the dis-
sociation constant of Ca21 binding to the SERCA pump (12,34,35,64, 65).
LEAKAGE FLUX FROM THE ER
JER;leak ¼ kER;leakð½Ca21 ER  ½Ca21 iÞ; (5)
where kER;leak (s
1) is the rate constant of Ca21 leak ﬂux through the ER
membrane (12,59).
IP3-DEPENDENT FLUX ACROSS THE PLASMA MEMBRANE FROM THE ECM INTO THE
CYTOSOL. This is a combined effect of ﬂux through various channels, in-
cluding the SOC, which open in response to the depletion of calcium in the
ER (20). Overall, this ﬂux acts as a positive feedback mechanism to maintain
cytosolic and ER calcium levels in anticipation of the emptying of the ER
and the calcium efﬂux to the ECM (18–20,66,67). Since JPM;IP3dep includes
the SOC ﬂux, a separate SOC ﬂux is not used.
JPM;IP3dep ¼ Vmax;PM;IP3dep½IP32=ðK2m;PM;IP3dep1 ½IP3
2Þ (6)
d½Ca21 i=dt ¼ biðJch1 JER;leak1 JPM;IP3dep  JSERCA  ðJPMCA1 JNCX  JPM;leakÞ1 ðJmit;out  Jmit;inÞ  2v21Þ
d½Ca21 ER=dt ¼ ðbER=rERÞðJSERCA  Jch  JER;leakÞ
dh=dt ¼ konðQ ð½Ca21 i1QÞhÞ
d½Ca21 mit=dt ¼ ðbm=rmÞðJmit;in  Jmit;outÞ: (1)
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LEAKAGE FLUX FROM THE ECM TO CYTOSOL (20)
JPM;leak ¼ vPM;leak:
CALCIUM EFFLUX FROM CYTOSOL TO ECM THROUGH THE PMCA AND NCX
JPMCA ¼ Vmax;PMCA;l½Ca
21 2
i
½Ca21 2i 1K2m;PMCA;l
1
Vmax;PMCA;h½Ca21 5i
½Ca21 5i 1K5m;PMCA;h
and
JNCX ¼ Vmax;NCX½Ca
21 i
½Ca21 i1Km;NCX
: (7)
JPMCAis due to two pumps, a low-capacity (high-afﬁnity) and a high-
capacity (low-afﬁnity) pump (34). Vmax;PMCA;l and Vmax;PMCA;h are the maxi-
mum capacities of the low and high capacity PMCA pump, respectively, and
Km;PMCA;l and Km;PMCA;h are the Ca
21 concentrations for half-maximal ﬂux
through the two pumps. Similarly, Vmax;NCX is the maximum ﬂux through the
Na1/Ca21 exchanger and Km;NCX is the corresponding Michaelis-Menten
constant for the binding of Ca21.
CALCIUM UPTAKE INTO AND EFFLUX FROM MITOCHONDRIA. Based on the model of
Marhl et al. (59), calcium ﬂux into mitochondria (68) is given by
Jmit;in ¼ kin½Ca21 4i =ðK42 1 ½Ca21 4i Þ; (8)
where kin is the maximum permeability for uptake of Ca
21 by the
mitochondrial uniporter and K2 is the half-maximal [Ca
21]i. Marhl et al. (59)
have used a Hill coefﬁcient of 8, since this uptake rate is quite steep with
respect to increased concentration of the cytosolic Ca21. However, we have
used a much smaller value of 4 (still quite steep) to be able to ﬁt experimental
data. The efﬂux term is given by
Jmit;out ¼ ðkout½Ca21 2i =ðK23 1 ½Ca21 2i Þ1 kmÞ½Ca21 mit; (9)
where kout is the maximal rate for the Na
1/Ca21 exchanger and permeability
transition pores (PTPs), K3 is the corresponding half-maximal [Ca
21]i for
efﬂux and km is the rate constant for a nonspeciﬁc leak ﬂux.
In the expression for dh/dt (Eq. 1), Q is an effective Michaelis constant
capturing the IP3Rchannel’s calcium-dependent inhibition, and is givenby (63)
Q ¼ Kinhð½IP31KIP3Þ=ð½IP31 d3Þ; (10)
where Kinh is the dissociation constant for Ca
21 binding to the inhibition site
and d3 is the dissociation constant of IP3 binding when the Ca
21 inhibitory site
is occupied. Finally, v21is the rate of reaction 21, the binding of two Ca
21 to
calmodulin (Fig. 1 B, box 4). The values of the parameters used in the above
expressions are listed in Table S2 (Supplementary Material). Initial conditions
for the state variables and the values of other parameters, such as the
concentrations of buffered species/enzymes, are listed in Supplementary
Material, Conservation parameters, buffered species and the initial conditions.
Solution of the ordinary differential equations, and parameter
estimation. The procedures for solving the ordinary differential equations
and parameter estimation using a hybrid stochastic-search-based algorithm
that combines genetic algorithm (GA), differential evolution (DE), and particle-
swarm optimization (PSO) are summarized in Supplementary Material. The
objective function and the constraints used for parameter estimation are also
given in Supplementary Material.
Prediction of dose response. We predicted the dose response of C5a
using the best set of parameter values for the master dataset. The C5a dose is
varied from 1 nM to 500 nM. Between different runs, the only change is in
the ligand strength i.e., [C5a] at t¼ tLA (time of ligand addition). To perform
the simulation, the system is solved to get the initial basal state (phase 1), and
then the system evolves at the basal conditions till t ¼ tLA (phase 2, part 1).
At t ¼ tLA, [C5a] is reset to the dose strength, e.g., 30 nM, corresponding to
the experimental dataset 1. All other initial conditions remain at the basal
steady-state level, and simulation is carried out (phase 2, part 2).
Sensitivity analysis. To consider both small and large changes, each
parameter (one at a time) is perturbed by multiplying its base value by fac-
tors [A, ¼, ½, 1, 2, 4, 8]. After simulation, the shift in the basal level
(baseline shift), the peak-height compared to the respective basal level, and
their sum, i.e., the peak height from the basal level for the base set, are
computed. Since our ﬁt-error function included both the good ﬁt to basal
level and good ﬁt to response after ligand addition, a weighted average of
normalized baseline shift B (weight 0.5), and normalized variation in peak
height (H) is used to rank the parameters. B is computed as the maximum
absolute baseline shift divided by the maximum peak height across the seven
perturbations. H is computed as the maximum absolute difference in peak
height across the seven perturbations divided by the maximum peak height.
Let bi be the baseline shift and hi be the peak height for the perturbations.
Then, mathematically,
B ¼ maxðabsðbiÞÞ=maxðhiÞ and
H ¼ ðmaxðhiÞ minðhiÞÞ=maxðhiÞ;
where hi is always nonnegative. The parameters are sorted in the decreasing
order of (0.5 3 B 1 H), i.e., from the most to least sensitive. It should be
noted that only the response of [Ca21]i is considered here for sensitivity.
Variation between different
subpopulations of cells
For a chosen strength of the ligand C5a, when the experiments were repeated
with multiple subpopulations of cells, though the qualitative response was
similar, substantial quantitative variation is observed in key features such as
basal level, peak height, etc. This variation is present across different
control datasets, as well as in the basal levels of knockdown cell lines. This
variability is an inevitable fact concerning biological systems (69). It cannot be
explained by using a single set of values of the kinetic parameters and the initial
conditions, since concentrations and ﬂuxes vary across subpopulations. As
mentioned earlier, if the basal levels were similar across different subpopu-
lations (datasets) without knockdown, a common set of parameter values could
have been used. However, in the data used, variation in the basal level even
without knockdown is asmuch as 30%of the peak height in somedatasets, e.g.,
compare datasets 1 and 2 (Fig. 2, panel 5, and Fig. 3, panel 2, in Results).
To utilize multiple datasets corresponding to different subpopulations of
cells without imposing unrealistic constraints, some of the parameters should
be allowed to vary. These parameters can be of the following types: 1), initial
condition of state variables ([R], [Gbg], and [Ga,iD]); 2), unknown variable
concentration of a buffered species (PLCbtot, [A], and [Arr]); 3), a lumped
parameter, speciﬁed externally or related to a lumped reaction, in which all
enzymes or modulators are not speciﬁed explicitly ([XPIP2_gen]); and
4), parameters related to the capacity and shape of cell (rER;Prtot;e; Prtot;x;
Prtot;ER; vmax;ch; Vmax; Vmax;PMCA;l; Vmax;PMCA;h; and Vmax;PM;IP3dep). Initial
conditions of [PIP2], [GRK] and [CaM] are allowed to vary across sub-
populations by allowing PIP2,tot, GRKtot, and CaMtot to vary, respectively.
Other parameters, such as those related to basic reactions are maintained
constant across datasets.
This ﬂexibility requires the generation of simulation/optimization code
that is dependent on the speciﬁcation of the data. This is the only effective
approach to utilize such data for kinetic modeling. Thus, a total of 19 pa-
rameters are allowed to vary from one subpopulation to another. Several
other combinations of fewer parameters were found to be unsatisfactory. The
parameters are separated into two classes, nonvarying and varying. Corre-
sponding to the chosen datasets, ﬁrst the master list of parameters is related
to one basic dataset (referred to as ‘‘Master dataset’’). Here, the ﬁrst dataset
(the control data on RGS10 knockdown) is chosen as the master dataset
(Supplementary Material, Table S3). The total number of parameters to be
estimated that are associated with the master dataset is 65. This includes kf,9,
which was optimized between 7.03 104 and 0.001 but later set to 0.001 to
get nearly full recovery of the receptor in 30–35 min. Of these 65 parameters,
46 are common to all subpopulations, whereas the 19 varying parameters are
instantiated for each dataset. Essentially, for each additional dataset, the list
of varying parameters is appended to the list. The list of varying parameters
is tracked so that during simulation stage, appropriate parameter assignment
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can be made for each dataset. The list of varying parameters cannot include a
calculated parameter. Any calculated parameters are recalculated to maintain
the constraints on the parameters.
With four datasets, the total number of unknown parameters becomes
46 1 4 3 19 ¼ 122, an increase by a factor of ;2. The total amount of
experimental data has increased by a factor of 4. Hence, at least in principle,
this scheme results in more constraints on the parameter space. In reality, the
result could be somewhat different, because with nonlinear dependence on
the parameters, even a small increase in the dimensionality of the search
space could result in substantial effective freedom in the search space. Since
the constraints described in Supplementary Material are applied to all
datasets, this problem gets alleviated to some extent.
There is one potential problem in letting the variable parameters vary for
different subpopulations across the entire range used for optimization. In
reality, the values of a variable parameter across different subpopulations are
within a certain factor of each other. For example, Vmax;PMCA;l is optimized
between 0.01 and 0.5. Its value for different subpopulations could be in the
range 0.05–0.12, within a factor of 2.4 of each other. Thus, constraints must
be imposed on how much such parameters could differ from each other
across different populations. We generate the values of such parameters (pi)
for the master dataset and then require that the corresponding values for
other datasets (populations), pki (for the k
th dataset), should be within a factor
range of 0.5–1.5 (user-deﬁned) as compared to pi; ensuring that such
parameters cannot deviate by more than a factor of 3 (¼ 1.5/0.5) between
any two datasets. Thus, the additional parameters for other datasets are not
the actual values of the parameters (pki ), but instead are the corresponding
ratios (rki ). Using the ratio r
k
i ; p
k
i is easily computed as p
k
i ¼ pi3 rki : The
resulting value is clipped at the lower or upper bound on the parameter value
and is then ready for use in simulation. The calculated parameters are re-
computed for each dataset with these corresponding values of the other pa-
rameters. A major advantage of this approach of handling the variability is
that the additional ratio parameters to be estimated are all in a small range of
(0.5–1.5) instead of being dependent on the optimization range of the actual
parameter itself. This approach provides an elegant way of relating the vari-
able parameters (intrinsic biochemical properties) of a knockdown dataset
and the corresponding control dataset.
FIGURE 2 Time course of several state variables including [Ca21]i for dataset 1 (control for knockdown of RGS with 30 nM C5a), as predicted by using the
best parameter values. (1) Fraction (percentage as compared to total surface receptors, Rtot) of free surface receptors ([R], solid line), ligand-bound active
receptors ([L.R], dashed line), internalized ligand-bound phosphorylated receptors ([L.Ri], dash-dotted line), and internalized free receptors ([Rp,i], dotted
line). Substantial change (decrease in [R] and increase in [L.R]) is observed soon after ligand addition (tLA ¼ 0 s). Upon phosphorylation, the active receptor,
L.R, gets internalized. Thus, [L.Ri] starts to increase after a few seconds and reaches its peak at ;120 s. As L.Ri dissociates into the ligand and Rp,i, [Rp,i]
shows an increase after a delay of ;20 s. (2) Percentage of Gbg in the free state (solid line) and bound to GRK (dash-dotted line), and percentage of active
G-protein ([Ga,iT], dashed line). All three lag behind [L.R] and exhibit qualitatively similar proﬁles. (3) Indicators of IP3-receptor channel activity: Q, the
effective Michaelis constant (solid line), and h (dashed line). As indicated by the arrow, the y axes forQ and h are on the left- and right-hand sides, respectively.
(4) Concentration of IP3 (solid line, the left y axis) and the fraction of unhydrolyzed PIP2 (dashed line, the right y axis). (5) Fit of the model prediction (dashed
line) to experimental data (solid line). (6) Time course of [Ca21]ER (the left y axis) and [Ca
21]mit (labeled as [Ca
21]m on the right y axis).
FIGURE 3 Time course of state variables for dataset 2 (control for knockdown of Gai with 100 nM C5a). (1) [IP3] (solid line, left y axis) and the fraction of
unhydrolyzed PIP2 (dashed line, right y axis). (2) Fit of the model prediction (dashed line) to the experimental data (solid line). (3) Time course of [Ca
21]ER
(solid line, left y axis) and [Ca21]mit (dashed, right y axis).
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Modeling of knockdown data
In the shRNAi-based knockdown cell lines, cells reach a new initial basal
state (AfCS protocol PP00000211 (23)). This new basal state is a
manifestation of the knockdown of the protein of interest. Hence, to model
the knockdown mathematically, once the values of the variable parameters
are assigned through the approach described in the previous section, the
knockdowns are emulated. Any calculated parameters that could be
dependent on the value of the variable being altered due to knockdown
are computed only then, and the initial basal steady state is computed. The
value with knockdown is computed as xKD ¼ x3ð1% knockdown=100Þ;
where x is the base value of the affected variable (initial condition,
concentration of a buffered protein, etc.) that would have been effective in
the absence of knockdown, xKD is the value with knockdown, and
%knockdown is the level of knockdown expressed in percentage.
It should be noted that for the ratio constraint on Gbg,tot/Ga,i,tot (Sup-
plementary Material, The objective function and the constraints), the values
before knockdown are used. After the knockdown, this ratio constraint need
not be satisﬁed, especially with the knockdown of Gbg or Ga,i (Ga,i2 and
Ga,i3). Further, the G-proteins from other families such as Ga,q are not
modeled. It is assumed that the total amount of all G-proteins in the cell is
around ﬁve times that of Ga,i. Since the experimental data on the knockdown
of Ga,i is based upon the actual cell, with no effect on other G-proteins, for
modeling purposes, the effective knockdown level is reduced by a factor of
5. Without this scaling, absurd values of the parameters and response were
obtained.
Modeling and prediction of knockdown response requires computation of
a new basal state for nontraining scenarios before simulating the model with
stimulus as described in Supplementary Material, Computation of new basal
state for knockdown scenarios.
RESULTS
Constrained parameter values and ﬁt to
experimental data
The detailed results of parameter estimation using the hybrid
genetic algorithm-differential evolution-particle swarm op-
timization approach are presented in Supplementary Mate-
rial. The essential results are presented here brieﬂy. The best
parameter values of the common parameters and the base
values of the variable parameters are listed in Table 1. Table
S6 (Supplementary Material) lists two other such parameter-
value sets that ﬁt the experimental data nearly to the same
degree as the best set and satisfy all constraints. Some param-
eters, such as Km;x; Prtot;ER; Km;NCX; and kmvary by a factor
of 1.5 or more across the three sets (Table S6), suggesting
some redundancy and nonlinear relationships among the
parameters.
Validation of the rapid-buffering assumption
Measurement of [Ca21]i through ﬂuorescence using fura-2
as well as Eq. 2 are based on the assumption that binding and
dissociation of [Ca21]i with the endogenous and exogenous/
mobile buffers is very rapid as compared to the timescale of
measurements (;4 s; interpolated at 1 s). The fact that the
association and dissociation rate constants are rarely spec-
iﬁed in the literature (46,47), suggests that these assumptions
are universally taken for granted. For the exogenous buffer
fura-2, a KD of 0.2–0.24 mM (Km;x in Table S2) is reported
(12,13,35). For endogenous buffer, Km;e  10mM for cyto-
solic proteins and Km;ER  1000mM for ER proteins is used.
Mishra and Bhalla (13) use a dissociation rate constant (kb)
of 1 s1 whenever unknown. At steady state, the net rate
of these reactions is zero. To test whether these reactions
quickly reach dynamic equilibrium when Ca21 levels change,
dynamic simulation of these reactions is carried out for two
different values of kb, viz. kb ¼ 0.1 and 1 s1. Km;x and Km;e
are chosen as in Table 1. During the transients, the ratio of
the rate of the reverse reaction to the forward reactions varies
between 0.68 and 1.28 for kb¼ 0.1 s1 and between 0.95 and
1.02 for kb ¼ 1.0 s1. Thus, for kb¼ 1.0 s1, the equilibrium
assumption is valid.
Constrained parameter values versus values based on
legacy data
As mentioned earlier, parameter-constraining using in vivo
data was necessary, since the legacy values based on in vitro
data in different cell types reported in the literature could not
TABLE 1 The best parameter values for dataset 1
Parameter name (unit) Value
Parameter
name Value
Prtot;e (mM) 1.91 E 1 02 Km;Cai2 :CaM 8.36 E  01
Km;e (mM) 2.43 E 1 00 Vmax;PM;IP3dep 2.26 E  01
Prtot;x (mM) 8.77 E 1 00 kf,1 5.89 E 1 01
Km;x (mM) 1.39 E  01 kb,1 2.02 E  01
Prtot;ER (mM) 6.02 E 1 04 kb,2 2.52 E 1 01
Km;ER (mM) 5.46 E 1 02 kf,3 1.22 E  01
rER 5.33 E  02 Km;Cai ;3 1.01 E  01
kon (mM/s) 1.04 E  01 kf,4 1.26E 1 02
Kinh (mM) 1.00 E 1 00 kf,5 2.05 E  03
vmax;ch (s
-1) 1.89 E  01 kf,6 6.62 E  04
KIP3 (mM) 1.36 E  01 kf,7 1.67 E 1 00
d3 (mM) 1.05 E 1 00 kf,8 5.00 E  03
Kact (mM) 8.14 E  02 kf,12 3.67 E  07
Vmax (mM/s) 1.14 E 1 02 kf,13 5.00 E  02
KP (mM) 7.54 E  01 kf,14 1.59 E 1 04
kER;leak (s
-1) 2.03 E  003 kb,14 4.18 E  02
Vmax;PMCA;l (mM/s) 8.93 E  02 kf,15 1.38 E  003
Km;PMCA;l (mM) 1.13 E  01 Km;GiD;15 6.81 E  02
Vmax;PMCA;h (mM/s) 5.90 E  01 kcat,16 1.54 E 1 00
Km;PMCA;h (mM) 4.42 E  01 Km,16 2.35 E  01
Vmax;NCX (mM/s) 1.00 E  01 kf,17 5.00 E  04
Km;NCX (mM) 1.00 E 1 00 kf,18 5.07 E 1 02
kin (mM/s) 5.06 E 1 02 Km;Cai ;18 3.64 E  01
kout (s
-1) 4.76 E 1 02 Km;Gbg ;18 3.64 E  01
K2 (mM) 9.92 E  01 kf,19 1.49 E 1 00
km (s
-1) 1.50 E  03 kf,22 1.10 E  02
PLCbtot 5.61 E  03 kb,22 2.75 E  03
PIP2,tot 1.29 E 1 02 [A] 1.02 E  02
XPIP2_gen 1.01 E  01 [Arr] 8.63 E  03
GRKtot 2.59 E  03 IC:[R] 4.11 E  02
Km,GRK 5.07 E  03 IC:[Gbg] 8.28 E  03
CaMtot 3.98 E 1 00 IC:[Ga,iD] 8.12 E  03
The values given are the same as in column 2 (Set 1, best) of Table S6,
and in the same order. The computed parameters are not listed here.
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predict experimental data even within an order of magnitude.
It is possible that the difference in the values of the individual
parameters based on in vitro or legacy data and in vivo data
may be small, but this difference is present in many param-
eters whose overall effect becomes very large. Here we com-
pare these values for some of the parameters to justify the use
of in vivo data for developing computational models.
Parameters for the receptoractivation/desensitization. The
bounds for these parameters, listed in Table S4 (Supplemen-
tary Material), were based on Hoffman et al. (48), Pumiglia
et al. (70), Woolf and Linderman (50), Chen et al. (71,72),
Daaka et al. (73), and Sklar and co-workers (74,75). None of
the values were measured or designed for the RAW 264.7
cell system. To cite a few examples, Hoffman et al. (48) used
kf,1 ¼ 84 6 19 mM/s, whereas Sklar et al. (74) used 17–27
mM/s for the N-formyl peptide receptor system. We used the
bounds 10–100 mM/s. The optimized/constrained value of kf,1
is 58.9 mM/s for the best set (Table 1). For the two other sets,
it is 60mM/s (Table S6). The bounds for kb,1, chosen similarly,
were 0.1–1 s1. Hoffman et al. (48) used kb,1¼ 0.376 0.1 s1
for the N-formyl peptide receptor system. The optimized
value is 0.2 s1 (Tables 1 and S6), well within a factor of 2,
even though they are different systems. We had also used the
constraint 0:001# kb;1=kf;1# 0:02mM that was based upon
the values suggested by Linderman and colleagues (48–50).
This constraint on the KD is also within the value suggested
speciﬁcally for C5a-C5aR, viz. 1–100 nM for neutrophils
and eosinophils, by Leslie (37). Thus, a fair amount of legacy
information was used to ensure that the constrained param-
eter values satisfy the biochemistry embedded in the liter-
ature values. The list goes on for the parameters related to
reactions 2–11. For brevity, we refer to Tables 1, S4, and S6
and the constraints listed in Supplementary Material.
Parameters for G-protein module (reactions 12–16). The
bounds for most of the parameters of these reactions were
chosen based upon the values suggested by Bornheimer et al.
(58), Ross and Wilkie (76), and Biddlecome et al. (77). Since
reactions 12 and 15 use the lumped scheme (Supplementary
Material), the parameter values suggested in Bornheimer
et al. (58), Ross and Wilkie (76), and Biddlecome et al. (77)
were scaled accordingly to compute the bounds. For reaction
12 (basal activity), the bounds on kf,12 were 1.0 3 10
7 to
3.03 106 mM/s (Table S4), whereas the optimized value is
3.67 3 107 for the best set (Table 1). Due to lumping, and
scaling of the parameter, this value cannot be directly
compared, but the values of the raw parameters were based
on a large body of literature (58). For reaction 13 (intrinsic
GTPase activity), the bounds on kf,13 were 0.05–0.07 s
1
(Table S4), as suggested by Ross and Wilkie (76) and Sprang
(78). The optimized value, 0.05 s1, actually matches exactly
with the value for the G-protein Ga,i1 (78,79). For RGS-
catalyzed hydrolysis (reaction 16), Ross and Wilkie (76)
report kcat,16 ¼ 15–25 s1 for Ga,q-PLCb and Ga,q-RGS4
systems. We allowed a range of 1–50 s1, since G-protein
Ga,i is from a different family (Table S4). The optimized
value is 1.54 s1 (Table 1). This lower value reﬂects the ob-
servation of Ross and Wilkie (76) that RGS has a selectivity
for Ga,q over Ga,i. Such corroborations increase our conﬁ-
dence that the parameter values are in the right range.
Parameters for the IP3 module. Since the mechanisms
proposed by Li and Rinzel (63) are directly used to model the
release of Ca21 from ER, the related parameters were con-
strained within the bounds gleaned from their work (63). The
notation used by Fink et al. (35) is used here. Despite some
relaxation to compensate for the simpliﬁcation, the opti-
mized values are quite close to those suggested by Li and
Rinzel (63). Several examples are given here. The optimized
value of kon; the on-rate constant for Ca
21 binding to an in-
hibitory site, 0.104 mM/s (Table 1) is close to the value 0.2
mM/s suggested by De Young and Keizer (62) and used by
Li and Rinzel (63), even though a wide bound of 0.1–4.0 was
speciﬁed (Table S2), since Fink et al. (35) had used a value of
2.7 mM/s. The same is true for Kinh; the KD for Ca
21 binding
to an inhibitory site. The bounds were 1–1.5 s1 (Table S2).
The optimized value is 1.0 s1, whereas Li and Rinzel (63)
have used 1.05 s1. Fink et al. (35) had used a much lower
value of 0.2 s1, but we biased it to Li and Rinzel’s value
(63) by specifying a lower bound of 1. For KIP3 (KM for
activation of IP3R by IP3), Hofer et al. (20) used 0.3 mM and
Li and Rinzel (63) used 0.13 mM (Table S2). We optimized
in the range 0.1–1, and the optimized value of 0.136 (Table
1) agrees well with data in Li and Rinzel (63). Similar
agreement is found for the parameters d3 and Kact (Tables S2
and 1).
Parameters for calcium dynamics. There are ;20
parameters related to various processes such as Ca21 bind-
ing to cytosolic and ER proteins, and exchange with the ER
across the plasma membrane and the mitochondria. The most
important parameters in regulating the calcium dynamics are
related to the exchange with ER (vmax;ch;Vmax; KP; and kER;leak)
and binding to the calcium-binding proteins (Prtot;e; Km;e;
Prtot;x; and Km;x). The bounds for vmax;ch (maximum intrinsic
channel ﬂux per mM of [Ca21]ER) were based upon com-
parison of the corresponding values used by Marhl et al.
(59), Lemon et al. (12), and Fink et al. (35) to get a peak ﬂux
of ;1.5 mM/s with [Ca21]ER ¼ ;200–500 mM (Table S2).
There is wide difference in the values used by Marhl et al.
(59) (4100 s1) and Lemon et al. (12) (575 s1). Both these
are very high, since the authors have used much lower
[Ca21]ER. We get an optimized value of 0.189 s
1. This low
value in our model is justiﬁed, since we have much higher
[Ca21]ER and much lower [Ca
21]i. As an example, Fink et al.
(35) use 3500 mM/s as maximum ﬂux and peak height of the
[Ca21]i time-course is as much as 1 mM. In our case, peak
height is;0.06 mM (experimental data), lower by a factor of
;17, and the equivalent maximum ﬂux is ;30–50 mM/s,
lower by a factor of ;70–100. After binding to the proteins,
the remaining excess calcium is cleared primarily by the
SERCA pump, which follows Hill dynamics with a¼ 2. The
ultrasensitivity and the saturation nature of the SERCA
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pump justify the need to get a 70–100 times lower maximum
ﬂux to get ;17 times lower peak height of [Ca21]i. The
optimized value of KP (half-saturation level for SERCA
pump), 0.754 mM, is about double the value used by Lemon
et al. (12), whereas Vmax (maximum ﬂux through the SERCA
pump), 114 mM/s, is ;2.5 times higher than that used by
Lemon et al. (12). Larger Vmax was necessary to get a ﬂux of
;1 mM/s, since [Ca21]i is about two to four times lower.
Such differences in the parameter values, as compared to
values reported previously for other speciﬁc or nonspeciﬁc
cell types, justify the in vivo data-based constraining of the
parameters. Although using the values reported in the liter-
ature for other cell types will result in similar gross quali-
tative shapes (e.g., ﬁrst rise and then return to basal levels),
the quantitative differences can be of more than an order of
magnitude as explained above. Even the ﬁner details of qual-
itative shape, such as the time constants for the rise and de-
cay phases, can differ signiﬁcantly, further strengthening the
case for cell-speciﬁc constraining of the parameters. The
bounds for the parameters Prtot;e; Km;e; Prtot;x; and Km;x were
based on values used by others (12,35,52,59). The optimized
value of Prtot;e; 191 mM, is about the same as used in Marhl
et al. (59) and Lemon et al. (12) (120–150 mM). The value of
Km;e; 2.43 mM, is lower than reported in Lemon et al. (12)
but much higher than 0.1 mM, the value used by Marhl et al.
(59). Thus, there is huge variation in the literature values.
Since Ca21 binds to the endogenous buffer with a low af-
ﬁnity, a value .1 mM is justiﬁed. On the contrary, Ca21 has
high afﬁnity for the exogenous buffer. For fura-2, Km;x ¼
0:2mM is mostly reported. In our model, we relaxed it some-
what to partially compensate for uncertainty in Prtot;e; Km;e;
and Prtot;x; but still the optimized value of 0.139 mM for the
best set is not much different. In fact, it is 0.2 mM for set 2.
The lower values ofKm;e andKm;x could be partially due to the
lower [Ca21]i. Somewhat higher Prtot;e could offset this, but
the fact that there are several pools of proteins with somewhat
different KD values points to the approximations made here.
Variation in parameters across datasets due to
sub-populational variability
Due to subpopulational variability within the best set itself,
the values of the variable parameters for the different datasets
are substantially different, as is evident from the values of
the ratio parameters listed in Table 2. In Table 2, ratio values
are listed for datasets 2–4. For dataset 1, this value is 1 by
default. As mentioned earlier (Materials and Methods), for
datasets 2–4, the actual value of the variable is computed by
multiplying the raw ratio (rki ) by the value of the parameter
for dataset 1 (pi) and then limiting the resulting value to the
lower or upper bound, i.e., pki ¼ pi 3 rki ; if pki , LB; pki ¼
LB; and if pki . UB; p
k
i ¼ UB: Then the true value of the
ratio parameter, reported in Table 2, is computed as rki;TRUE ¼
pki =pi: Of all the 19 ratio parameters, the range of variation
(MAX/MIN ratio across the four datasets) is ,1.5 for eight
parameters. For the parameters rER; vmax;ch; and Vmax;PMCA;l;
this range is $2, which is not surprising since all three exert
large control on calcium dynamics through the size factor,
maximal ﬂux through the IP3R channel, and the expulsion of
calcium to the extracellular space. For other parameters, the
range of variation is between 1.5 and 2. Overall, these values
suggest that substantial variation is exhibited by different
subpopulations of cells. The speciﬁcs of how these differ-
ences help explain the observed variety of calcium response
in different datasets is presented below in the context of ﬁt to
experimental data.
Consistency of the model and parameters with
experimental data and the relevance of
subpopulational variability
Figs. 2–5 show the ﬁt of the predicted [Ca21]i to the cor-
responding experimental data for the four datasets. The pre-
dicted time course for other key variables and biochemical
species such as the concentrations of free surface receptors
and ligand-bound active receptors, free Gbg, h, and the con-
centrations of IP3, [Ca
21]ER, etc., are also shown. Before
getting into the details of the speciﬁc features of the dynamic
response, it should be noted that good ﬁt between the ex-
perimental data used for estimating the parameters and the
model predictions corresponding to the best set of parameter
values is obtained (Figs. 2, panel 5, 3, panel 2, 4, panel 5,
and 5, panel 2). The main features of the predicted dynamic
response for each dataset are discussed below.
TABLE 2 Values of the ratio parameters for parameters that
vary among datasets and the computed parameters (for best
parameter-value set only)
Ratio values
Parameter name Dataset 2 Dataset 3 Dataset 4 MAX/MIN
rER 1.00 E 1 00 1.26 E 1 00 5.74 E  01 2.19 E 1 00
Prtot;e 1.02 E 1 00 5.28 E  01 5.68 E  01 1.92 E 1 00
Prtot;x 5.61 E  01 8.62 E  01 9.43 E  01 1.78 E 1 00
Prtot;ER 7.30 E  01 1.12 E 1 00 9.66 E  01 1.53 E 1 00
vmax;ch 5.30 E  01 1.50 E 1 00 1.50 E 1 00 2.83 E 1 00
Vmax 1.08 E 1 00 1.38 E 1 00 1.04 E 1 00 1.38 E 1 00
PLCbtot 1.31 E 1 00 8.92 E  01 1.44 E 1 00 1.62 E 1 00
PIP2,tot 9.44 E  01 9.44 E  01 1.24 E 1 00 1.32 E 1 00
XPIP2_gen 1.22 E 1 00 9.89 E  01 9.89 E  01 1.24 E 1 00
IC:[R] 9.73 E  01 1.07 E 1 00 1.23 E 1 00 1.27 E 1 00
IC:[Gbg] 9.67 E  01 9.67 E  01 9.67 E  01 1.03 E 1 00
GRKtot 1.16 E 1 00 1.16 E 1 00 9.65 E  01 1.20 E 1 00
CaMtot 7.15 E  01 5.53 E  01 5.99 E  01 1.81 E 1 00
IC:[Ga,iD] 9.85 E  01 9.85 E  01 9.85 E  01 1.02 E 1 00
[A] 9.42 E  01 1.17 E 1 00 1.18 E 1 00 1.25 E 1 00
[Arr] 1.39 E 1 00 9.27 E  01 9.27 E  01 1.50 E 1 00
Vmax;PM;IP3dep 6.62 E  01 7.44 E  01 1.10 E 1 00 1.67 E 1 00
Vmax;PMCA;l 5.00 E  01 5.11 E  01 6.82 E  01 2.00 E 1 00
Vmax;PMCA;h 8.48 E  01 1.50 E 1 00 9.53 E  01 1.77 E 1 00
Parameters computed using steady-state constraints:
vPM;leak 1.45 E  02 1.31 E  02 1.49 E  02 1.40 E 1 00
IC:[Ca21]ER 3.48 E 1 02 3.18 E 1 02 2.55 E 1 02 1.54 E 1 00
IC:[Ca21]mit 9.11 E  02 9.22 E  02 7.30 E  02 1.42 E 1 00
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Dataset 1 illustrates the dynamic response of various
modules. Results for dataset 1 (the master dataset, the
control for RGS knockdown with addition of 30 nM C5a) are
shown in Fig. 2.
ACTIVATED RECEPTOR IS QUICKLY DESENSITIZED AND REMAINS INTERNALIZED FOR A
LONG TIME. Fig. 2, panel 1 shows the dynamic response of
several species from the receptor module. C5a binds to C5aR
quickly, and within seconds a substantial increase in [L.R]
and a sharp decrease in [R] are observed. After the ﬁrst few
seconds, [R] reaches a pseudo-steady-state level of 10–11
nM  (Rtot – 30) (Table 1). As L.R gets phosphorylated,
[L.R] starts to decrease. Some L.Rp gets internalized. Thus,
[L.Ri] starts to increase and reaches its peak at ;120 s. As
L.Ri dissociates into the ligand and Rp,i, [Rp,i] increases after
a delay of ;20 s. Interestingly, [L.Ri] remains high for a
long time, since its dissociation rate, kf,8 ¼ 0.005 s1, is low
(Table 1). Likewise, Once [Rp,i] reaches a high level within
10 min, it remains high for even longer since the receptor
recovery is even slower (kf,9 ¼ 0.001 s1). A more detailed
analysis of the receptor recovery is presented in the
companion to this article.
NEGATIVE FEEDBACK REGULATION OF RECEPTOR ACTIVITY IS MEDIATED BY THE
ACTIVATED G-PROTEIN. Fig. 2, panel 2 shows the dynamics of
G-protein. Since the activation of G-protein follows the
activation of the receptor, [Gbg], [GRK.Gbg], and [Ga,i] lag
behind [L.R]. Further, they exhibit qualitatively similar
proﬁles. The peak levels of [Gbg] and [GRK.Gbg] are in an
;3:1 ratio. Substantial GRK.Gbg results in quick desensi-
tization of the activated receptor.
LARGE VARIATION IN Q AND A RELATIVELY SMALLER VARIATION IN h IS
OBSERVED. Fig. 2, panel 3 displays the time course of Q, the
effective Michaelis constant (solid lines), and h (dashed
lines). Q varies between 0.2 and 0.4, whereas variation in h
is much smaller. The peak of Q precedes the peak of h by
5–10 seconds, and both rise and decay of h is slower than
that of Q. Q closely follows [IP3] (Fig. 2, panels 3 and 4)
because signðdQ=dtÞ ¼ signðd½IP3=dtÞ with KIP3,d3 (62).
PEAK IP3 LEVELS ARE MORE THAN FIVE TIMES HIGHER THAN THE BASAL LEVEL. Fig.
2, panel 4 shows [IP3] and the fraction of unhydrolyzed PIP2.
The maximal [IP3] (;0.4 mM) is 6–7 times higher than the
basal level. Only,4% of PIP2 is hydrolyzed and most of that
is present as the phosphorylation product of IP3, IP3,p. The
actual values of the fraction of open IP3R channels are
different from their equilibrium values (not shown); dh/dt is
justiﬁed (Eq. 1). However, this departure from equilibrium is
small compared to that observed in oscillatory scenarios (63).
THE MODEL AND THE PARAMETERS ARE CONSISTENT WITH DATA. Fig. 2,
panel 5 shows the excellent ﬁt of the model prediction to
experimental data. The peaks are quite close both in terms of
magnitude and the occurrence time. The rise and decay
phases are also captured well.
MITOCHONDRIAL UPTAKE IS SLOWER COMPARED TO THE ER UPTAKE. Fig. 2,
panel 6 shows the time course of [Ca21]ER and [Ca
21]mit
(labeled [Ca21]m). As [Ca
21]i starts to increase, [Ca
21]ER
starts to decrease, since Ca21 comes out of ER. As [Ca21]i
increases, [Ca21]mit also increases. Even though the dynam-
ics of Jmit;out has a Hill dynamics dependence on [Ca
21]i, due
to a large value of K3, Jmit;out is small and, hence, decay of
[Ca21]mit starts after a longer time.
Dataset 2 provides computational evidence of subpopula-
tional variability in several components. The results for
dataset 2 (the control dataset for knockdown of Gai with
addition of 100 nM C5a at tLA ¼ 20 s) are shown in Fig. 3.
The qualitative features of the quantities shown in panels 1–3
of Fig. 2 for dataset 1 are quite similar to those for dataset 2.
Hence these are not shown again for dataset 2. One exception
is the response of [R], which is similar to its response for
dataset 3 (Fig. 4, panel 1). This is because in both datasets 2
and 3, the ligand strength is 100 nM. Here, we discuss the
response of [IP3] and [PIP2] (Fig. 3, panel 1), ﬁt of predicted
[Ca21]i to the experimental data (Fig. 3, panel 2) and the
response of [Ca21]ER and [Ca
21]mit (Fig. 3, panel 3).
HIGHER PLCb POOL RESULTS IN HIGHER PEAK [IP3]. As shown in
panel 1, the peak [IP3] level for dataset 2 is higher compared
to dataset 1. This can be attributed to higher C5a (100 nM)
and a higher level of PLCbtot (ratio factor 1.31, Table 2),
other factors such as Rtot, Gbg, and PIP2,tot being similar
(Table 2). Higher PLCbtot is sufﬁcient to result in higher
levels of [IP3]. As will be discussed later, the half-maximal
effect concentration (EC50) for dose response of C5a, the
dose required to reach half-maximal response, is ;18 nM,
well below 30 nM. Hence, 100 nM C5a would not cause a
substantial increase in the peak [IP3] levels compared to 30
nM C5a. Thus, the higher level of [IP3] is mainly attributed
to higher PLCbtot. In fact, the ratio 1.31 correlates well with
the ratio of the peak levels of [IP3] for datasets 1 and 2 (Figs.
2, panel 4 and 3, panel 1).
SUBPOPULATIONAL VARIABILITY EXPLAINS ANOMALOUS PEAK CALCIUM RESPONSE.
Fig. 3, panel 2 shows the excellent ﬁt of the predicted
data to the experimental data. It can be noted that even
though the basal levels of [Ca21]i and several other species
such as [IP3] and [PIP2] are different between datasets 1 and
2, the height of the peaks of [Ca21]i are quite similar. The
ratio of the peak values of [Ca21]i is 0.097/0.086 ¼ 1.13. At
ﬁrst this appears paradoxical, due to a higher peak level of
[IP3]. However, this anomaly can be resolved by observing
the subpopulational variability. In particular, vmax;ch; the max-
imal ﬂux through the IP3R channels, is only half as compared
to its value for dataset 1 (ratio 0.53, Table 2). Other differences
in the values of the parameters for datasets 1 and 2 that help
explain this anomaly are described in Supplementary Mate-
rial, Similar peak-heights of [Ca21]i for datasets 1 and 2.
LARGER BASAL [Ca21]I REQUIRES LARGER [Ca
21]ER AND LEADS TO LARGER
[Ca21]MIT. Fig. 3, panel 3 shows that [Ca
21]ER and [Ca
21]mit
are both higher during the basal steady state, as well as
during the transients compared to dataset 1. This is rea-
sonable, since basal [Ca21]i is also higher for dataset 2.
Further, since Vmax is higher, a higher level of [Ca
21]ER is
required to maintain the sought basal state. A lower value of
vmax;ch also contributes to this, albeit to a lesser degree.
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Dataset 3 sheds light on the altered state upon the
knockdown of Gai. The results for dataset 3 (85% knock-
down of Gai, with addition of 100 nM C5a at tLA ¼ 20 s) are
shown in Fig. 4. The layout of the ﬁgure is similar to that of
Fig. 2 for dataset 1.
HIGH-DOSE RESULTS IN DEPLETION OF THE SURFACE RECEPTORS. Since the
ligand concentration, 100 nM, is higher than Rtot ¼ 41 nM,
shortly after ligand addition, [R] drops to almost 0 (Fig. 4,
panel 1). After the ﬁrst few seconds [L.R] also drops quickly
and most of the receptor is present as L.Ri and Rp,i. The
dynamics of the receptor module for dataset 2 is similar.
KNOCKDOWN OF GaI RESULTS IN HIGHER BASAL AND PEAK LEVELS OF [Gbg]
AND [IP3]. Fig. 4, panel 2 shows the response of the GTPase
cycle module. Even though the qualitative shapes of the
time-evolution plots are similar to those seen in panel 2 of
Fig. 2, there are two major quantitative differences. The ﬁrst
is that the basal levels of [Gbg] and [GRK.Gbg] are well
above zero, because due to the knockdown of Gai there is not
enough GaiD to bind with Gbg, and hence, some Gbg is
present in the free active state. [GRK.Gbg] follows a similar
trend. The second difference is that the peak activity of the
G-protein is relatively higher. The direct consequence of the
higher levels of [Gbg] is higher basal and peak levels of [IP3]
and Q, and both follow a common trend, as discussed for
dataset 1 (Fig. 4, panels 3 and 4).
THE RESPONSE OF Q AND h ARE QUALITATIVELY OPPOSITE. The dynamic
response of h is very different compared to other datasets
(Fig. 4, panel 3). After an initial increase in h with [IP3] and
Q, h quickly reaches its equilibrium value (with respect to
[IP3] or Q) and then starts to decrease even though Q is still
rising. The reason is that [Ca21]i and h reach high enough
levels to make dh/dt negative. Clearly, the biphasic behavior
of the channel opening is the result of an increase in [IP3] and
[Ca21]i and a decrease in h. Higher depletion of PIP2 is
observed (Fig. 4, panel 4).
KNOCKDOWN OF GaI RESULTS IN PARTIAL DEPLETION OF THE ER. The ﬁt to
experimental data in this case is good (Fig. 4, panel 5). Basal
levels are similar to those for dataset 2. However, since the
basal level of [IP3] and, hence, the open fraction of IP3R
channels, is higher for dataset 3 compared to dataset 2, to
achieve similar [Ca21]i, a lower basal [Ca
21]ER is required
(Fig. 4, panel 6). The large slope of [Ca21]i during the rise
phase also required a higher value of vmax;ch (Table 2). With
these accumulating increasing effects, to satisfy the desired
peak response and slope of the decay phase, a higher Vmax is
required (Table 2).
AT HIGHER [Ca21]I, RESPONSE IS HASTENED DUE TO ULTRASENSITIVITY. Basal
[Ca21]mit is similar to that for dataset 2 but higher than for
dataset 1 (Fig. 4, panel 6). However, peak [Ca21]mit is much
higher compared to any other dataset, due to the ultrasen-
sitive dependence of Jmit;in on [Ca
21]i. With increased
[Ca21]mit, the decay phase is also steeper compared to other
datasets (Fig. 4, panel 6). Another distinction deserving
mention is that as the response returns toward the basal level,
in datasets 1 and 3, [Ca21]ER approaches from a lower level
(i.e., it does not cross the basal level), whereas for dataset 2,
it approaches the basal state from above the basal level (after
t  120 s). This could have been the onset point for
oscillation if high levels of [IP3] could have been sustained
for a longer time leading to somewhat higher [Ca21]i.
Dataset 4 also validates the necessity of subpopulational
variability. The results for dataset 4 (83% knockdown of
PLCb, with addition of 100 nM C5a at tLA¼ 20 s) are shown
in Fig. 5. The three panels are similar to the panels in Fig. 3
for dataset 2.
SUBPOPULATIONAL VARIABILITY IS REQUIRED. In Fig. 5, panel 1, it is
clear that due to reduced PLCb, lower [IP3] is obtained. In
fact, PLCbtot without knockdown is actually higher than for
dataset 1, viz. the ratio PLCbtot,set 4/PLCbtot,set 1 ¼ 1.44
(optimized value); otherwise, even lower peak [IP3] would
have been observed. As much as 98.5% of PIP2 remains
unhydrolyzed.
OSCILLATIONS ARE NOT POSSIBLE. The plots in Fig. 5, panel 2 sug-
gest a good ﬁt to experimental data during the rise and the
initial decay. However, during the later phase, the ﬁt is not
good. We discard the possibility of oscillations here and
conclude that there is some sort of systematic error in the
measurement itself; oscillations can occur only if [Ca21]i
drops much below its basal levels due to very high activity of
the SERCA pump while maintaining high [IP3]. None of this
is observed since [IP3] levels are well below 0.2 mM (Fig. 5,
panel 1) and [Ca21]i approaches the basal level from above
the basal level (Fig. 5, panel 2). Given that the basal level of
[Ca21]i is between the corresponding values for datasets
1 and 3, a similar trend for basal [Ca21]ER is reasonable
(Fig. 5, panel 3).
Prediction of dose response
Dose response of a ligand is one of the most useful and
experimentally measurable indicators of the ligand efﬁcacy
for a target. We predicted the dose response as outlined in
Materials and Methods. The main results are described
below.
FULL RESPONSE RESULTS FROM 75 NM C5A, AND WITH INCREASING DOSE, THE
RISE TIME DECREASES. The simulation results are presented in Fig.
6. Fig. 6 A shows the temporal response of [Ca21]i for
increasing doses of C5a. The doses shown are for C5a¼ [1 2
3 5 10 20 30 50 75 100 250 500] nM. Response for all state
variables is near saturation for C5a ¼ 50 nM, and it is
difﬁcult to distinguish between the curves for C5a$ 75 nM.
The temporal response curve for 30 nM C5a for which
experimental data is available is labeled to show that ;80%
saturation is achieved at this level. The time to reach peak
decreases as the C5a dose is increased. This is because of
the partial switchlike ultrasensitive behavior of JSERCA with
respect to [Ca21]i. More precisely, at lower doses, due to low
Jch; to reach sufﬁcient [Ca
21]i and JSERCA; longer time is
needed. Though not very visible in the plot, near the peaks,
the curve for C5a ¼ 50 nM is slightly to the right compared
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to the curves for higher doses. Also, the curve for C5a ¼ 30
nM crosses the curves for higher doses at t $ 30 s. It is
difﬁcult to suggest that this crisscross behavior could be
related to the EC50 value for the ligand.
HIGHER DOSES RESULT IN BIMODAL RESPONSE OF THE ACTIVATED RECEPTORS.
Fig. 6 B shows the fraction (percentage) of the total recep-
tors that are bound to the ligand and active (Rtot¼ 0.041 mM
for each simulation). Since receptor activation is the ﬁrst step
in the cascade after ligand binding, the active fraction in-
creases rapidly and then starts to decrease as the active re-
ceptor gets phosphorylated. The maximal fraction of active
receptors is close to 100% suggesting that for C5a $ 100
nM, receptors are indeed saturated. As shown later, since L
and R bind in a 1:1 ratio, the EC50 level for C5a is about half
of Rtot. After about t ¼ 100 s, some of the receptors are re-
cycled back. For lower doses, all the ligand is used up by this
time, and hence, [L.R] does not show an increase after this
time. However, for C5a$ 50 nM, since some unused ligand
remains in the system, as soon as some receptor is recycled,
an increase in [L.R] is observed (not visible). Receptor re-
cycling will be discussed in greater detail in the companion
to this article.
THE TOTAL SURFACE RECEPTOR, AND NOT THE TOTAL Gbg, IS THE LIMITING
FACTOR FOR THE MAXIMAL RESPONSE. Fig. 6 C shows the fraction of
free active [Gbg]. The trend is similar to that for the active
receptor shown in Fig. 6 B but with a slight delay and a larger
effective time constant, because the GTPase cycle module is
the second stage in the cascade. Similar to [L.R], with C5a$
50 nM, a secondary increase in [Gbg] is observed after t .
100 s. Even with almost all the receptor active, maximal free
[Gbg] is only 40%. Also, due to the basal activity of the
GTPase cycle,;2.3% of total [Gbg] is free in the absence of
the ligand. Had the total number of surface receptors been
larger, larger maximal [Gbg] could have been observed.
Thus, the total amount of receptors seems to be the bottleneck
for obtaining a higher response. In fact, it is easy to see that
there are saturation or maximal capacity effect at various
stages of the signaling cascade. For example, if Rtot were not
the bottleneck, then the next bottleneck would be Gbg,tot, as
[Gbg] is limited by Gbg,tot. It is this capacity limit that results
FIGURE 4 Time course of state variables for dataset 3 (85% knockdown of Gai with 100 nMC5a). (1) Fraction of [R] (solid line), [L.R] (dashed line), [L.Ri]
(dash-dotted line), and [Rp,i] (dotted line). (2) Percentage of [Gbg] (solid line) and [GRK.Gbg] (dash-dotted line), and percentage of [Ga,iT] (dashed line). (3)Q
(solid line, left y axis), and h (dashed line, right y axis). (4) [IP3] (solid line, left y axis) and the fraction of PIP2 (dashed line, right y axis). (5) Fit of the model
prediction (dashed line) to experimental data (solid line). (6) Time course of [Ca21]ER (solid line, left y axis) and [Ca
21]mit (dashed line, right y axis).
FIGURE 5 Time course of state variables for dataset 4 (83% knockdown of PLCb with 100 nM C5a). (1) [IP3] (solid line, left y axis) and the fraction of
PIP2 (dashed line, right y axis). (2) Fit of the model prediction (dashed line) to experimental data (solid line). (3) Time course of [Ca
21]ER (solid line, left y axis)
and [Ca21]mit (dashed line, right y axis).
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in M-M or Hill dynamics (ultrasensitivity) effect in signaling
modules.
DOSE RESPONSE SHOWS ULTRASENSITIVITY AND THE EC50 VALUE IS ABOUT HALF
THE TOTAL SURFACE RECEPTORS. Fig. 6 D shows the dynamic
response of [IP3], which is nearly identical to that of [Gbg]
qualitatively. The dynamic response of [Ca21]ER shown in
Fig. 6 E is qualitatively similar to that of [Gbg] and [IP3]
except that [Ca21]ER decreases as the ligand is applied. Fig. 6
F shows the dose-response curve. The sigmoidal shape on
the semilog plot indicates the ultrasensitivity effect. The
EC50 value of C5a is18 nM and the effective Hill coefﬁcient
is ;2. As mentioned earlier, the EC50 value is about half of
Rtot. In fact, the value of 18 nM is based on the intersection of
the dose-response curve with the half-maximal horizontal
line on the semilog plot. On a linear-scale plot, this value
turns out to be ;20 nM, which is even closer to half of Rtot.
Indeed, the maximal response is limited by Rtot. Starting
from the ligand to the cytosolic Ca21, there are several mech-
anisms that exhibit M-M kinetics or ultrasensitivity. The
receptor module, the GTPase module and the PLCb module
exhibit M-M kinetics for the relevant ﬂuxes, whereas Jch
shows ultrasensitivity with a coefﬁcient of 3 with respect to
the preceding events, e.g., activation level of the IP3R. Hence
one might expect a hill coefﬁcient (a) of 5 or even more for
the dose-response curve. However, in practice, a . 2 is
rarely observed. This is because one of the stages/modules
serves as the limiting module, e.g., Rtot in this case. Hence,
effectively, 1 , a , 2 is observed. In fact, on a linear scale,
the dose-response curve appears to exhibit M-M behavior.
The ultrasensitivity of the expression for JSERCA also counter-
balances the ultrasensitivity of the activation steps. Finally,
the qualitative shape of the dose-response curve is similar to
those obtained by Mishra and Bhalla (13) for glutamate
stimulus (Fig. 5 in (13)).
THE EC50 VALUE OF 18–20 NM IS COMPARABLE TO THOSE OBSERVED IN THE AFCS
DATA (5–20 NM). As mentioned earlier, substantial variation is
observed between the control experiments for different
knockdowns. As an example, the peak height for the control
for knockdown of Gb-2 is ;70 nM for 100 nM C5a (ID
ECD031202B (29)), whereas for control of knockdown of
C5aR the peak height is ;45 nM for 10 nM C5a (ID
ECD031118B) and ;50 nM for 100 nM C5a (ID
ECD031118B), suggesting that EC50 could be even below
5 nM, depending on Rtot.
Multiparametric variability analysis
Given the nonlinearity of the system, to comprehensively
assess the effect of changes in the parameters and the im-
portant initial states, using the results of optimization, a multi-
parametric variability analysis (MPVA) is carried out (58,80).
In this approach, the parameter values obtained during the
stochastic-search-based optimization that ﬁt the data well
are analyzed. The parameters are sorted according to their
FIGURE 6 Prediction of dose response of C5a using the parameters for the master dataset. As the C5a dose is varied from 1 nM to 500 nM, the system is
simulated each time and dynamic responses of [Ca21]i and several other state variables is recorded. (A) Temporal response of [Ca
21]i for increasing doses of
C5a. The response for C5a ¼ 30 nM, for which experimental data is available, is labeled. The time to reach peak decreases as the C5a dose is increased. (B)
Fraction (percentage) of the receptor in ligand-bound active form (Rtot¼ 0.041mM for each simulation). Since receptor activation is the ﬁrst step in the cascade
after ligand binding, the active fraction increases rapidly and then starts to decrease as the active receptor gets phosphorylated. (C) Fraction of free-active [Gbg].
The trend is similar to that for the active receptor but with a slight delay and a larger effective time constant. Even with almost all the receptor active, maximal
free [Gbg] is only 40%. Also, due to the basal activity of the GTPase cycle,;2.3% of total [Gbg] is free in the absence of the ligand. (D) Dynamic response of
[IP3]. (E) Dynamic response of [Ca
21]ER. (F) Dose response curve: The sigmoidal shape on the semilog plot indicates the ultrasensitivity effect. The half-
maximal effect concentration (EC50) of C5a is 18 nM and the effective Hill coefﬁcient is ;2.
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decreasing range (ratio of the maximum to minimum value,
MAX/MIN) across this good set of parameter values. The sys-
tem is less sensitive to the parameters with larger MAX/MIN
or range (80). On the contrary, the system is more sensitive to
the parameters with a narrow range (80). Table S7 (Sup-
plementary Material) lists the important statistics about the
parameters and then lists the parameters in the order of in-
creasing MAX/MIN, i.e., from most to least important. The
four most constrained parameters are IC:[Gbg], IC:[Ga,iD],
kf,18, and GRKtot, in that order (IC stands for initial condition).
This makes sense, because any imbalance in Gbg,tot or Gai,tot
leads to large changes, as observed in dataset 3. kf,18 directly
affects the production of IP3, and hence it is a crucial parameter.
Similarly, GRKtot is important since GRK competes against
Ga,iD for binding to Gbg. Using the values of the parameters
across the good sets, a pseudoprobability distribution is
computed for each parameter. The probability distribution,
plotted in Fig. S2 and discussed in Supplementary Material,
shows that good diversity wasmaintained during optimization.
Since the MAX andMIN values can potentially depend on
the lower bound and upper bound used in optimization and
on the cutoff ﬁt-error used to deﬁne the good sets, the regular
parametric sensitivity analysis is also carried out.
Parametric-sensitivity analysis
First, the sensitivity of temporal calcium response, peak
height, and basal level to changes in individual parameters is
studied. Then sensitivity of dose response is studied. Finally,
global change in the parameters is studied. Whenever ap-
propriate, results are compared with those obtained by Mishra
and Bhalla (13).
Sensitivity analysis of temporal response
As described in Materials and Methods, a weighted criterion,
0.5B 1 H (where B is the normalized baseline-shift and H is
the normalized variation in the peak height), is used to rank
the parameters according to sensitivity. The resulting list is
shown in S8 (Supplementary Material). Table S8 lists only
those parameters for which B$ 0.05 or H$ 0.5 to indicate a
sufﬁciently large change in the response for parametric devi-
ation ranging over a factor of 64. The most sensitive param-
eters according to sensitivity analysis are IC:[Gbg], IC:[Ga,iD],
kER;leak and KP (dissociation constant for SERCA pump). For
these parameters, the temporal response and baseline-shift,
peak height, and their sum are shown in Fig. 7. Baseline-shift
and/or peak height are very large for each of these param-
eters. Both kER;leak and KP exert strong control on the basal
level, since during the basal state the leakage ﬂux from the
ER to the cytosol is balanced mainly by the SERCA pump
ﬂux back to the ER. Though the baseline shift and the sum of
baseline shift and peak height are monotonic as the param-
eter is increased, the same is not true about the peak height
itself. Peak height shows highly nonlinear behavior for changes
in IC:[Gbg] and IC:[Ga,iD]. They are not even monotonic.
The peak heights decrease for an increase as well as a de-
crease in the value of these two parameters. Peak height is
nonmonotonic for kER;leak; whereas it is monotonic for KP:
The nonmonotonic nature is due to excessive baseline shift.
Most of the parameters listed in column 3 are related to the
production of IP3 or the binding of IP3 to the IP3R channel.
This is in agreement with the legacy knowledge about the
crucial role of ER and IP3 dynamics in regulating the cy-
tosolic calcium (62,63,81–87). Mishra and Bhalla (13) report
similar results on the central role of IP3 dynamics. It should
be noted that here, only [Ca21]i response is included for
sensitivity analysis. If the response of some other compo-
nents, such as [IP3], [L.R], etc., also were included in the
sensitivity analysis, the ranking would potentially change.
Comparison of the sorted lists of parameters in Tables S7 and
S8 shows that despite some differences, the group of the ﬁrst
15–20 most sensitive parameters is the same in both tables.
For example, IC:[Gbg] and IC:[Ga,iD] are at the top in both
lists. kf,18, GRKtot (Table S7, near the top) are within the ﬁrst
18 most sensitive parameters in Table S8. Similarly, kER;leak
and KP(Table S8, near the top) are the 15th and 12th most
sensitive parameters in Table S7. Thus, MPVA and param-
etric sensitivity analysis provide complementary views.
Perturbation of IC:[Ga,iD] is especially interesting be-
cause our results show that at reduced IC:[Ga,iD], the relative
peak height is decreased, since the basal level is increased
substantially (Fig. 7, top row, two rightmost panels). This is
in agreement with the pattern observed in the AfCS data on
knockdown of IC:[Ga,iD] (29). Thus, our model can explain
both an increase and a decrease in peak height for the knock-
down of Ga,i.
These results for the remaining 32 parameters listed in
Table S8 are similar (not shown). Other details are listed in
Table S8. For many parameters, the baseline shift was neg-
ligible, whereas the change in peak height was substantial.
For these parameters, the peak height is monotonic with in-
creasing value of the parameter. The peak height is non-
monotonic for parameters kf,19, PIP2,tot, and KIP3. Most of the
parameters with no baseline shift are related to the reactions.
Also, for the enzymatic reactions and other M-M kinetics and
Hill-dynamics-based expressions, the monotonic natures for
parameters Vmax and Km are opposite. Some examples include
reaction 18 (kf,18 and Km;Gbg ;18 and Km;Cai;18), parameters Vmax
and KP (Fig. 7), and parameters Vmax;PMCA;l and Km;PMCA;l:
Dose response under single-parameter variation
For a chosen parameter, the value of the parameter is
perturbed by the factors [A¼½ 1 2 4 8], and dose response is
predicted for each case. The maximum deviation from the
basal level of the base response with no perturbation is
considered the peak height, max(D[Ca21]i). Since increase in
the dose results in higher peaks (Fig. 5 F), the parameters
resulting in increase in overall peak height (the sum), such as
IC:[Gbg], kER;leak; and KP in Fig. 7, and IC:[R] (not shown),
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further increase the peak height at higher doses. However,
for the parameters resulting in decrease in the overall peak
height, such as IC:[Ga,iD] in Fig. 7 and KIP3 (not shown), a
more interesting pattern of dose response is obtained. This
is elucidated in Fig. 8 A, panel 1, which shows the dose-
response surface for variations in IC:[R] and the C5a dose.
Fig. 8, panel 2 shows the dose response surface for variations
inKIP3: There appear to be three distinct regimes characterized
by low KIP3 and high C5a dose (large peak); high KIP3 and
high C5a dose (short peak); and low KIP3 and low C5a dose
(medium peak). Similar behavior is obtained for perturbation
in other parameters, depending upon their behavioral similar-
ity to IC:[R] or KIP3: Variation in IC:[R] does not affect the
basal level, but a decrease in KIP3 leads to increased basal
levels. These effects are visible at very low C5a in Fig. 8 A.
Global perturbation
Another type of perturbation involved simultaneous change
in all rate-constant parameters such as forward and reverse
rate constants, kf and kb, and enzymatic rate constants Vmax
and kcat. Such parameters are listed in Table S9 (Supple-
mentary Material). Parameters such as Km and Prtot,e were
not changed. In one case, these parameters were increased
twofold and in another decreased by 50% compared to their
base values. Such a scenario is likely to occur, for instance,
when the temperature of the system is altered. Fig. 8 B, left
and right, shows the responses of [IP3] and [Ca
21]I, re-
spectively, in these scenarios. The relative baseline shift, as
compared to the peak height without perturbation, is ,2%
for the [IP3] response whereas for [Ca
21]I, it is 50% and
36% for increase and decrease, respectively. On the con-
trary, the peak-height, measured from the respective basal
levels, varies between 19% and 15% for [IP3] and between
11% and 6% for [Ca21]i. Thus, the response of both [IP3]
and [Ca21]i is very robust for reasonable physiological
variations. These results are consistent with those observed
by Mishra and Bhalla (13). The time to reach the peak and
then return to basal level is decreased (increased) with in-
creased (decreased) values of the parameters.
FIGURE 7 Temporal response, baseline shift, and peak height for perturbation in the parameters IC:[Gbg], IC:[Ga,iD], kER;leak; and KP: For each parameter,
two panels are used. The temporal response is shown in the left panel for which the x axis is labeled time (s). The baseline shift and peak height are shown in the
right panel for which the x axis is labeled as log2-ratio: Æparameter nameæ. The sum of baseline shift and peak height is also plotted in the right panels. In the
left panel, the direction of increasing value of the parameter is shown.
FIGURE 8 (A) Dose-response surface for variation in a chosen parameter and the C5a dose. (1) Surface for the parameter IC:[R]. (2) Surface for the
parameter KIP3: (B) Effect of simultaneous increase or decrease in all kinetic parameters. (Left) Response for [IP3]. (Right) Response for [Ca
21]i.
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DISCUSSION
We have developed a kinetic model to characterize the
intracellular calcium dynamics in RAW 264.7 cells in
response to the anaphylaxin C5a that activates PLCb via the
G-protein Gi upon binding to its receptor C5aR. The in vivo
data from the AfCS allowed us to constrain the parameters
within the ranges suggested by legacy knowledge and in
other cell types. This was achieved through an optimization
approach. It should be noted that in test simulations using the
parameter values as presented in the literature, the experi-
mental data could not be produced. This is not surprising
because most of the mechanisms can be similar across dif-
ferent cell types, but the parameters can vary substantially
not only across different cell types (13,21) but also across
different subpopulations of cells. Thus, parameter constrain-
ing was essential. Further, as Mishra and Bhalla (13) have
suggested, the parameters based on in vitro data can be dif-
ferent from those suitable for use with in vivo data. Inter-
estingly, the optimized values of the parameters related to the
IP3R dynamics are quite close to their literature values (62).
Our model, although it is coarse-grained and hence relatively
simplistic, captures most of the mechanisms included in the
models presented in the literature for nonexcitable cells and
metabotropic receptors. The model is context-speciﬁc in that
the mechanisms for the receptor and G-protein module are
for the G-protein Gi, though they are easily extensible to
other GTPase cycles. The EC50 value of C5a for the dose-
response curve is about half of the total pool of surface re-
ceptors. We have included some mechanisms explicitly to
facilitate quantitative modeling of the knockdown of many
proteins, including GRK, Gbg, Ga,i, and PLCb, on which in
vivo data is available from AfCS. Besides incorporating the
three-site model of IP3 and Ca
21 binding to IP3R (62,63) to
demonstrate the CICR effect, interaction with the mitochon-
dria and the ECM have also been modeled. Interaction with
the ECM is important for knockdowns resulting in a baseline
shift, e.g., the experimental data on knockdown of Ga,i (Ta-
ble S3, dataset 3). The recent evidence about the presence of
IP3R channels on the plasma membrane provides further
support for this effect (18,19,66,67).
Methodological novelty
The methodological novelty of this work is the ability to
utilize multiple datasets exhibiting subpopulational variabil-
ity, a biological fact of living cells, and in vivo data (69). Our
approach reveals a challenge for both the experimentalists
and the modelers alike in that none of them alone can handle
it efﬁciently, since the number of parameters to be con-
strained increases linearly with the number of datasets to be
used. This, essentially, leads to lesser constraining of the
parameter space even though the ratio-based approach alle-
viates this effect. The success of this method is evident as all
the four datasets used for constraining the parameters are
predicted well in terms of basal levels, peak height, qual-
itative shape, and rise time. In fact, this approach has made it
possible to resolve the anomalous observation on the re-
sponse for the knockdown of PLCb (dataset 4), as compared
to the basal data (dataset 1).
Dose response
Dose response provides insights into the capacity of the
cellular system and the local perturbation of the receptor-
ligand binding system. The dose response predicted by our
model agrees with those observed in the AfCS data within
the subpopulational variability. The EC50 value of 18–20 nM
is within the suggestive range of 5–20 nM. Since it has been
observed that EC50 is about half of Rtot due to the 1:1 binding
ratio of C5a/C5aR, Rtot can be computed using EC50 values
obtained from carefully controlled experiments, serving as a
soft sensor. The dose-response analysis has revealed that the
peak response is dependent on the capacity of all the mod-
ules and, in general, is limited by the least-capacity module
as the species in that module saturate ﬁrst. The ultrasen-
sitivity of the dose response is due to the multiple steps in-
volved in the cascade from the receptor activation to calcium
release from the ER and the saturation effect.
Multiparametric variability analysis and
sensitivity analysis
Most parameters were constrained within an order of mag-
nitude (Table S7). As much as half of the sensitive param-
eters are related to the production of IP3, IP3R channel kinetics,
or other release and uptake mechanisms (Tables S7 and S8).
These have been the focus of both theoretical (62,63) and
experimental research in regard to the maintenance of the
homeostasis of intracellular calcium (81,85,87) and its role in
physiological effects such as neurological processes (88,89)
and heartbeat (90). Thus, MPVA can serve as a useful heu-
ristic to identify most of the sensitive parameters without
carrying out local or large perturbations in the parameters
separately. However, sensitivity analysis is also required
as this approach complements the MPVA approach. Global
sensitivity analysis has shown that the system is very robust
to physiological perturbations such as small changes in
temperature (13).
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
The supporting document ‘‘calcium_paper_Supplementary-
part-1.pdf’’ contains additional text, the Tables S1–9 and the
Figures S1–2.
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